Jacobs Levy Equity Management Inc. Takes $9.11 Million Position in Option Care Health, Inc. $OPCH

Jacobs Levy Equity Management Inc. purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 260,541 shares of the company's stock, valued at approximately $9,106,000. Jacobs Levy Equity Management Inc. owned 0.16% of Option Care Health as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also bought and sold shares of OPCH. Schonfeld Strategic Advisors LLC purchased a new stake in shares of Option Care Health during the fourth quarter worth about $533,000. Ameriprise Financial Inc. grew its position in shares of Option Care Health by 4.3% during the fourth quarter. Ameriprise Financial Inc. now owns 193,702 shares of the company's stock worth $4,494,000 after purchasing an additional 7,922 shares in the last quarter. BNP Paribas Financial Markets purchased a new stake in shares of Option Care Health during the fourth quarter worth about $1,311,000. Balyasny Asset Management L.P. grew its position in shares of Option Care Health by 338.0% during the fourth quarter. Balyasny Asset Management L.P. now owns 168,082 shares of the company's stock worth $3,900,000 after purchasing an additional 129,708 shares in the last quarter. Finally, Deutsche Bank AG grew its position in shares of Option Care Health by 8.5% during the fourth quarter. Deutsche Bank AG now owns 637,305 shares of the company's stock worth $14,785,000 after purchasing an additional 50,149 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Insiders Place Their Bets

In other news, Director Norman L. Wright acquired 3,411 shares of Option Care Health stock in a transaction on Tuesday, September 9th. The shares were bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the acquisition, the director directly owned 15,501 shares of the company's stock, valued at $454,334.31. This trade represents a 28.21% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The shares were purchased at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the acquisition, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 59,411 shares of company stock worth $1,627,576 in the last ninety days. 0.64% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently issued reports on OPCH. Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, JMP Securities increased their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Trading Down 3.0%

Shares of OPCH stock traded down $0.89 on Friday, reaching $28.48. 1,626,043 shares of the company's stock were exchanged, compared to its average volume of 1,842,623. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $4.62 billion, a PE ratio of 22.78, a P/E/G ratio of 1.79 and a beta of 0.82. The company's fifty day simple moving average is $29.09 and its 200 day simple moving average is $31.43.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the company earned $0.30 EPS. Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.